SLD — Saluda Medical Cashflow Statement
0.000.00%
Last trade - 00:00- AU$2.85bn
- AU$3.14bn
- $70.36m
- 10
- 36
- 63
- 27
Annual cashflow statement for Saluda Medical, fiscal year end - June 30th, USD millions except per share, conversion factor applied.
2023 June 30th | 2024 June 30th | 2025 June 30th | |
|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final |
| Net Income/Starting Line | -92.2 | -97.8 | -149 |
| Depreciation | |||
| Non-Cash Items | 11.8 | 8.54 | 43.6 |
| Unusual Items | |||
| Other Non-Cash Items | |||
| Changes in Working Capital | -7.58 | -6.66 | -15.1 |
| Change in Accounts Receivable | |||
| Change in Inventories | |||
| Change in Prepaid Expenses | |||
| Change in Other Assets | |||
| Change in Payable / Accrued Expenses | |||
| Change in Taxes Payable | |||
| Other Operating Cash Flow | |||
| Cash from Operating Activities | -85.7 | -93.3 | -118 |
| Capital Expenditures | -2.37 | -1.08 | -1.27 |
| Purchase of Fixed Assets | |||
| Cash from Investing Activities | -2.37 | -1.08 | -1.27 |
| Net Issuance / Retirement of Stock | |||
| Net Issuance / Retirement of Debt | |||
| Cash from Financing Activities | 144 | -0.284 | 97.9 |
| Foreign Exchange Effects | |||
| Beginning Cash Balance | |||
| Ending Cash Balance | |||
| Net Change in Cash | 55.1 | -94.9 | -17.3 |